ERG Antikörper (full length)
Kurzübersicht für ERG Antikörper (full length) (ABIN7878179)
Target
Alle ERG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- ERG Antibody / Transcriptional regulator ERG (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant human full-length ERG protein was used as the immunogen for the ERG antibody.
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the ERG antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the ERG antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ERG (ERG, ETS transcription factor (ERG))
-
Andere Bezeichnung
- ERG
-
Hintergrund
- The transcription factor erythroblastosis virus E26 transforming sequence related gene (ERG) functions as a regulator of key cellular functions to promote endothelial homeostasis. Expression of ERG has been observed in both benign and malignant vascular endothelial tumors, such as hemangiomas and Kaposi sarcomas, respectively. Carcinomas of the breast, colon, and urothelium have demonstrated absence of ERG expression, whereas presence of the protein has been confirmed in a subset of prostate carcinoma cases. Anti-ERG can be a useful tool for identifying vascular endothelial neoplasms and distinguishing prostate carcinoma from epithelial tumors of non-prostatic origin.
-
UniProt
- P11308
Target
-